These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12799049)

  • 1. Mammary gland-specific secretion of biologically active immunosuppressive agent cytotoxic-T-lymphocyte antigen 4 human immunoglobulin fusion protein (CTLA4Ig) in milk by transgenesis.
    Lui VC; Tam PK; Leung MY; Lau JY; Chan JK; Chan VS; Dallman M; Cheah KS
    J Immunol Methods; 2003 Jun; 277(1-2):171-83. PubMed ID: 12799049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients.
    Stadlbauer TH; Schaub M; Korom S; Onodera K; Sayegh MH; Kupiec-Weglinski JW
    Transplantation; 1997 Dec; 64(12):1816-22. PubMed ID: 9422425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells expressing soluble CTLA4Ig prolong antigen-specific skin graft survival.
    Ierino FL; Mulley W; Dodge N; Li YQ; Mouhtouris E; Christiansen D; Sandrin MS
    Immunol Cell Biol; 2010; 88(8):846-50. PubMed ID: 20404834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
    Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
    Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion of CTLA4Ig by an SV40 T antigen-transformed islet cell line inhibits graft rejection against the neoantigen.
    Lew AM; Brady JL; Silva A; Coligan JE; Georgiou HM
    Transplantation; 1996 Jul; 62(1):83-9. PubMed ID: 8693551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of CTLA4Ig secreted by transgenic fetal pancreas allografts.
    Sutherland RM; Brady JL; Georgiou HM; Thomas HE; Lew AM
    Transplantation; 2000 May; 69(9):1806-12. PubMed ID: 10830215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression.
    Guillot C; Mathieu P; Coathalem H; Le Mauff B; Castro MG; Tesson L; Usal C; Laumonier T; Brouard S; Soulillou JP; Lowenstein PR; Cuturi MC; Anegon I
    J Immunol; 2000 May; 164(10):5258-68. PubMed ID: 10799887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin-specifically transgenic expression of biologically active human cytoxic T-lymphocyte associated antigen4-immunoglobulin (hCTLA4Ig) in mice using lentiviral vector.
    Jiang W; Zhou XY; Wang LL; Liu Q; Liu C; Wang Y; Wei H
    Transgenic Res; 2012 Jun; 21(3):579-91. PubMed ID: 21983813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic control of oligosaccharide modification in the mammary gland: linking recombinant human erythropoietin functional analysis of transgenic mouse milk-derived hEPO.
    Kwon DN; Song H; Park JY; Lee SY; Cho SK; Kang SJ; Jang JS; Seo HG; Kim JH
    Transgenic Res; 2006 Feb; 15(1):37-55. PubMed ID: 16475009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
    Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
    Transplantation; 2001 Oct; 72(8):1423-32. PubMed ID: 11685115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced survival of grafts genetically endowed with the ability to block CD2 and B7.
    Brady JL; Yamashita K; Lew AM
    Cell Transplant; 2001; 10(2):175-81. PubMed ID: 11332632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac allograft tolerance induced by intra-arterial infusion of recombinant adenoviral CTLA4Ig.
    Yang Z; Rostami S; Koeberlein B; Barker CF; Naji A
    Transplantation; 1999 Jun; 67(12):1517-23. PubMed ID: 10401757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of donor-specific immunoregulatory T-cells after local CTLA4Ig gene transfer to pancreatic allograft.
    Miao G; Ito T; Uchikoshi F; Akamaru Y; Kiyomoto T; Komodo H; Song J; Nozawa M; Matsuda H
    Transplantation; 2004 Jul; 78(1):59-64. PubMed ID: 15257039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.
    Sayegh MH; Zheng XG; Magee C; Hancock WW; Turka LA
    Transplantation; 1997 Dec; 64(12):1646-50. PubMed ID: 9422396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic blockade of CD28-B7-mediated T-cell costimulation by CTLA4Ig reduces intimal thickening in MHC class I and II incompatible mouse heart allografts.
    Glysing-Jensen T; Räisänen-Sokolowski A; Sayegh MH; Russell ME
    Transplantation; 1997 Dec; 64(12):1641-5. PubMed ID: 9422395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of human CTLA4Ig expressed in transgenic rice cell suspension cultures.
    Lee SJ; Park CI; Park MY; Jung HS; Ryu WS; Lim SM; Tan HK; Kwon TH; Yang MS; Kim DI
    Protein Expr Purif; 2007 Feb; 51(2):293-302. PubMed ID: 17079164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
    Woodward JE; Qin L; Chavin KD; Lin J; Tono T; Ding Y; Linsley PS; Bromberg JS; Baliga P
    Transplantation; 1996 Oct; 62(7):1011-8. PubMed ID: 8878397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning, expression and bioassay of canine CTLA4Ig.
    Shin IS; Choi EW; Chung JY; Hwang CY; Lee CW; Youn HY
    Vet Immunol Immunopathol; 2007 Jul; 118(1-2):12-8. PubMed ID: 17482679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self in vivo production of a synthetic biological drug CTLA4Ig using a minicircle vector.
    Rim YA; Yi H; Kim Y; Park N; Jung H; Kim J; Jung SM; Park SH; Ju JH
    Sci Rep; 2014 Nov; 4():6935. PubMed ID: 25374010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation.
    Reddy B; Gupta S; Chuzhin Y; Kalergis AM; Budhai L; Zhang M; Droguett G; Horwitz MS; Chowdhury JR; Nathenson SG; Davidson A
    Transplantation; 2001 Mar; 71(6):801-11. PubMed ID: 11330546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.